Skip to content
OpenCapital
Get started

Cabaletta Bio, Inc. CABA Q1 2026 earnings

Reported May 14, 2026 · Before market open

Diluted EPS-$0.39Beat by $0.02
Revenue estimate$1.7M
EPS estimate-$0.41

Next report

Aug 6, 2026 (In 3 weeks)
Revenue estimate$1.7M
EPS estimate-$0.37

Versus estimates

Revenue

Q4 2024$1.6M

Diluted EPS

Q1 2026-$0.39Beat by $0.02
Q4 2025-$0.40Beat by $0.05Q3 2025-$0.44Beat by $0.05Q2 2025-$0.73Miss by $0.02Q1 2025-$0.71Miss by $0.04Q4 2024-$0.65In line

Ask the moment Cabaletta Bio, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Cabaletta Bio, Inc. report Q1 2026 earnings?
Cabaletta Bio, Inc. (CABA) reported Q1 2026 earnings on May 14, 2026 before market open.
What were Cabaletta Bio, Inc.'s Q1 2026 revenue and EPS?
Cabaletta Bio, Inc. reported diluted EPS of $-0.39 for Q1 2026.
Did Cabaletta Bio, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-0.41 by $0.02.
How did Cabaletta Bio, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS grew 45.1% from $-0.71.
Where can I find Cabaletta Bio, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001759138-26-000024) and the 10-Q periodic report (0001759138-26-000026) directly on SEC EDGAR. The filing index links above go to sec.gov.